| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Institut Gustave Roussy [A. Sp., S. B.], Department of Pathology [A. Sp.] and U. 521, INSERM [S. B.] 94800, Villejuif, France, and UPR 2169, Centre National de la Recherche Scientifique, Cancer Research Institute, B. P. 8-94801, Villejuif, France [G. G-M., A. Sa]
Xeroderma pigmentosum (XP) is an inheritable disease characterized by sun-sensitivity and a high frequency of skin cancers including melanoma. We have analyzed two different groups of XP: the XP complementation group C (XP-C), deficient in global nucleotide excision repair but proficient in transcription-coupled repair and associated with a very early onset of skin cancers; and the XP variant (XPV), deficient in the bypass of DNA photoproducts. To get new insights into the biology of melanoma in XP patients, we studied 20 melanomas from four XP-C and two XPV patients in terms of pathology, immunohistochemistry of p53, mutations in exons 49 of the p53 gene, and polymorphisms of the p53 gene at codon 72. All statistical tests were two-sided. The majority of the XP melanomas were of the lentigo maligna melanoma (LMM) type, as found in the elderly. p53 point mutations were found in 60% of XP-C melanomas and in only 10% of XPV melanomas, this latter frequency being similar to what has been reported in the general population. Mutations show the specific UV-signature because the majority were CC to TT tandem and C to T transitions located at the bipyrimidine sites known to be hotspots of UV-induced DNA lesions. All DNA lesions giving rise to mutations in XP-C melanomas were located on the nontranscribed strand of the p53 gene, demonstrating that these patients cells were able to carry out preferential repair in vivo. The LMMs found in XP-C are associated with an accumulation of unrepaired DNA lesions and may represent a good model for the LMM induction in the elderly.
This article has been cited by other articles:
![]() |
L. A. Fecher, S. D. Cummings, M. J. Keefe, and R. M. Alani Toward a Molecular Classification of Melanoma J. Clin. Oncol., April 20, 2007; 25(12): 1606 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Markovic, L. A. Erickson, R. D. Rao, R. R. McWilliams, L. A. Kottschade, E. T. Creagan, R. H. Weenig, J. L. Hand, M. R. Pittelkow, B. A. Pockaj, et al. Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis Mayo Clin. Proc., March 1, 2007; 82(3): 364 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mitchell Revisiting the photochemistry of solar UVA in human skin PNAS, September 12, 2006; 103(37): 13567 - 13568. [Full Text] [PDF] |
||||
![]() |
S. Arad, N. Konnikov, D. A. Goukassian, and B. A. Gilchrest T-oligos augment UV-induced protective responses in human skin FASEB J, September 1, 2006; 20(11): 1895 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Bastian, A. B. Olshen, P. E. LeBoit, and D. Pinkel Classifying Melanocytic Tumors Based on DNA Copy Number Changes Am. J. Pathol., November 1, 2003; 163(5): 1765 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. You, D.-H. Lee, J.-H. Yoon, S. Nakajima, A. Yasui, and G. P. Pfeifer Cyclobutane Pyrimidine Dimers Are Responsible for the Vast Majority of Mutations Induced by UVB Irradiation in Mammalian Cells J. Biol. Chem., November 21, 2001; 276(48): 44688 - 44694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |